These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34599966)

  • 1. USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells.
    Xia X; Liu X; Chai R; Xu Q; Luo Z; Gu J; Jin Y; Hu T; Yu C; Du B; Huang H; Ou W; Liu S; Liu N
    J Biol Chem; 2021 Nov; 297(5):101258. PubMed ID: 34599966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo.
    Wu YJ; Sala-Newby GB; Shu KT; Yeh HI; Nakayama KI; Nakayama K; Newby AC; Bond M
    J Vasc Surg; 2009 Nov; 50(5):1135-42. PubMed ID: 19878790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein.
    Sicari BM; Troxell R; Salim F; Tanwir M; Takane KK; Fiaschi-Taesch N
    Endocrinology; 2012 Feb; 153(2):861-72. PubMed ID: 22210745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of S phase kinase-associated protein 2 by NR4A orphan nuclear receptor NOR1 in vascular smooth muscle cells.
    Gizard F; Zhao Y; Findeisen HM; Qing H; Cohn D; Heywood EB; Jones KL; Nomiyama T; Bruemmer D
    J Biol Chem; 2011 Oct; 286(41):35485-35493. PubMed ID: 21868379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Skp2 degradation with troxerutin decreases neointima formation.
    Liu X; Chai R; Xu Q; Zou M; Jiang S; Liu Y; Li R; Kong T; Chen X; Xu R; Liu S; Zhang Z; Liu N
    Eur J Pharmacol; 2024 Nov; 982():176947. PubMed ID: 39209097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The USP10/13 inhibitor, spautin-1, attenuates the progression of glioblastoma by independently regulating RAF-ERK mediated glycolysis and SKP2.
    Kona SV; Kalivendi SV
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167291. PubMed ID: 38857836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation.
    Wu YJ; Bond M; Sala-Newby GB; Newby AC
    Circ Res; 2006 May; 98(9):1141-50. PubMed ID: 16574903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPKα2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells.
    Song P; Wang S; He C; Wang S; Liang B; Viollet B; Zou MH
    Circ Res; 2011 Nov; 109(11):1230-9. PubMed ID: 21980125
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhang W; Zhao J; Deng L; Ishimwe N; Pauli J; Wu W; Shan S; Kempf W; Ballantyne MD; Kim D; Lyu Q; Bennett M; Rodor J; Turner AW; Lu YW; Gao P; Choi M; Warthi G; Kim HW; Barroso MM; Bryant WB; Miller CL; Weintraub NL; Maegdefessel L; Miano JM; Baker AH; Long X
    Circulation; 2023 Jul; 148(1):47-67. PubMed ID: 37199168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flavo-oxidase QSOX1 supports vascular smooth muscle cell migration and proliferation: Evidence for a role in neointima growth.
    Borges BE; Appel MH; Cofré AR; Prado ML; Steclan CA; Esnard F; Zanata SM; Laurindo FR; Nakao LS
    Biochim Biophys Acta; 2015 Jul; 1852(7):1334-46. PubMed ID: 25766108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic effect of p21Cip1 on smooth muscle cell proliferation: role of PI 3-kinase and Skp2-mediated degradation.
    Bond M; Sala-Newby GB; Wu YJ; Newby AC
    Cardiovasc Res; 2006 Jan; 69(1):198-206. PubMed ID: 16212951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine cooperates with adrenal androgen dehydroepiandrosterone sulfate to attenuate PDGF-induced proliferation of vascular smooth muscle cell A7r5 through Skp2 signaling pathway.
    Liu J; Xiu J; Cao J; Gao Q; Ma D; Fu L
    Mol Cell Biochem; 2011 Sep; 355(1-2):127-34. PubMed ID: 21533767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury.
    Jia S; Chen Z; Li J; Chi Y; Wang J; Li S; Luo Y; Geng B; Wang C; Cui Q; Guan Y; Yang J
    J Mol Cell Cardiol; 2014 Sep; 74():173-82. PubMed ID: 24857820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin protects against balloon injury‑induced neointima formation in rats by regulating proliferation and migration of vascular smooth muscle cells via the TGF‑β1/Smad3 signaling pathway.
    Song T; Zhao J; Jiang T; Jin X; Li Y; Liu X
    Int J Mol Med; 2018 Oct; 42(4):2155-2162. PubMed ID: 30066831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BubR1 insufficiency inhibits neointimal hyperplasia through impaired vascular smooth muscle cell proliferation in mice.
    Kyuragi R; Matsumoto T; Harada Y; Saito S; Onimaru M; Nakatsu Y; Tsuzuki T; Nomura M; Yonemitsu Y; Maehara Y
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):341-7. PubMed ID: 25524773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.